Public Health | March 17, 2022
Community approach crucial to stamp out diseases
The Karnataka Health Promotion Trust held a day-long session in New Delhi to address health care challenges
The Karnataka Health Promotion Trust held a day-long session in New Delhi to address health care challenges
The open-label, multicenter, randomized Phase 1 trial is designed to evaluate the safety and immunogenicity of experimental HIV trimer mRNA vaccines
Amit Jaju, Senior Managing Director, India in an interview with Thomas C Thottathil outlined the steps Indian pharma companies should follow to be compliant with global regulatory requirements
Lynparza is approved in the US, EU, Japan and several other countries for the treatment of patients with gBRCAm, HER2-negative, metastatic breast cancer previously treated with chemotherapy based on results from the OlympiAD Phase III trial
Agreement builds on 15 years of successful collaboration between AbbVie and Richter, including globally launched cariprazine products
Transformative closed-loop technology senses the spinal cord's response to stimulation and instantaneously adjusts therapy to sustain durable, optimized treatment
With over 20 years of international leadership experience, Dr. Amrein has led many teams and organizations across over 30 geographies
Toyobo will start looking at ways to use the knowhow from DMC’s sophisticated fermentation process technologies to enhance the efficiency of making its bioproducts
Commits to plant 5000 trees in phase 1 with its partner SankalpTaru Foundation
Launched in 2020, C-TAP aims to facilitate timely, equitable and affordable access to Covid-19 health products by boosting their production and supply through open, non-exclusive licensing agreements
Subscribe To Our Newsletter & Stay Updated
